| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |